世界中医药
文章摘要
引用本文:浦明之1,鞠娅1,何焕荣1,孙钢1,彭贵清1,吴娟娟1,余松1,陆艳2,徐俊华1.皱肺定喘膏对慢性阻塞性肺疾病急性加重及相关炎症介质的临床观察[J].世界中医药,2024,(07):.  
皱肺定喘膏对慢性阻塞性肺疾病急性加重及相关炎症介质的临床观察
Clinical Observation on the Effect of Zhoufei Dingchuan Ointment on Inflammatory Mediators and Acute Exacerbation of Chronic Obstructive Pulmonary Disease
投稿时间:2022-05-29  
DOI:10.3969/j.issn.1673-7202.2024.07.018
中文关键词:  慢性阻塞性肺疾病  吴门膏方  炎症介质  531行动倍增计划  皱肺定喘膏  稳定期  肺功能  急性加重
English Keywords:Chronic obstructive pulmonary disease  Wumen paste  Inflammatory mediator  531 action plan  Zhoufei Dingchuan ointment  Stable stage  Pulmonary function  Acute exacerbation
基金项目:国家自然科学基金项目(81704025);江苏省科技计划项目社会发展类重大科技示范项目(BE2019674);苏州市卫生计生委项目(LCZX201816);苏州市卫生计生委项目(SZXK202112);苏州市科技局项目(SYSD2020150);苏州市科学技术局项目(SS201806);苏州市科学技术局项目(SLT201965);苏州市“科教兴卫”青年科技项目(KJXW2021048)
作者单位
浦明之1,鞠娅1,何焕荣1,孙钢1,彭贵清1,吴娟娟1,余松1,陆艳2,徐俊华1 1 南京中医药大学附属苏州市中医医院苏州215000 2 苏州市疾病预防控制中心苏州215000 
摘要点击次数: 21
全文下载次数: 0
中文摘要:
      目的:观察皱肺定喘膏对慢性阻塞性肺疾病(COPD)患者急性加重次数及相关炎症介质的影响。方法:选取2019年4月至2020年4月苏州市中医医院和通安卫生院收治的稳定期COPD患者66例作为研究对象,随机分为对照组(n=32)和膏方组(n=34)。对照组予以噻托溴铵吸入剂治疗,膏方组在对照组治疗的基础上加用皱肺定喘膏,比较2组治疗后急性加重次数及急性加重风险炎症指标白细胞介素-6(IL-6)、IL-8、IL-17a、肿瘤坏死因子-α(TNF-α)的变化情况。结果:膏方组在治疗后COPD急性加重次数低于对照组(P<0.05);膏方组治疗后IL-6、TNF-α、IL-17a水平明显降低,优于对照组(均P<0.05),IL-8水平与对照组比较,差异无统计学意义(P>0.05)。结论:皱肺定喘膏可抑制COPD稳定期患者体内的IL-6、TNF-α、IL-17a水平,减少急性加重次数,从而发挥治疗作用。
English Summary:
      To observe the effect of Zhoufei Dingchuan ointment on the times of acute exacerbation and inflammatory mediators of patients with chronic obstructive pulmonary disease(COPD).Methods:A total of 66 COPD patients in stable stage admitted to Suzhou Hospital of Traditional Chinese Medicine and Tong'an Health Center from April 2019 to April 2020 were selected and randomly divided into control group(n=32) and ointment group(n=34).The control group was given tiotropium bromide inhalation and the ointment group was additionally treated with Zhoufei Dingchuan ointment based on the control group treatment.The times of acute exacerbation and the inflammatory mediators of acute exacerbation risk interleukin(IL)-6,IL-8,IL-17a,and tumor necrosis factor(TNF)-α in the two groups were compared.Results:After treatment,the times of acute exacerbation of COPD in the ointment group were lower than those in the control group(P<0.05).The level of IL-6,TNF-α,and IL-17a in the ointment group was more significantly decreased compared with the control group(P<0.05).Conclusion:Zhoufei Dingchuan Ointment can inhibit the level of IL-17a,IL-6,and TNF-α in COPD patients in stable stage and reduce the times of acute exacerbation,thus helping treat COPD.
查看全文  查看/发表评论  下载PDF阅读器